From a financial perspective, robotic technologies remain inaccessible for many patients.Robotic treatment is costly and considered experimental,basedon the limited evidence base, which means insurers do not typically cover it. An initial analysis of the VA Robotics study suggests that the short-term cost of robotic intervention may be offset by lower medical costs over time (Wagner et al., 2011), however, more robust study is warranted to better understand their economic impact.
From a financial perspective, robotic technologies remain inaccessible for many patients.Robotic treatment is costly and considered experimental,basedon the limited evidence base, which means insurers do not typically cover it. An initial analysis of the VA Robotics study suggests that the short-term cost of robotic intervention may be offset by lower medical costs over time (Wagner et al., 2011), however, more robust study is warranted to better understand their economic impact.
正在翻译中..